[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Observation
June 2015

Corneal Endothelial Cell Loss and Iritis Associated With a New Cosmetic Iris Implant

Author Affiliations
  • 1St Paul Eye Clinic, St Paul, Minnesota
  • 2Department of Ophthalmology and Visual Neurosciences, University of Minnesota, St Paul
  • 3Department of Ophthalmology, State University of New York Downstate, Brooklyn
JAMA Ophthalmol. 2015;133(6):723-724. doi:10.1001/jamaophthalmol.2015.0488

Anterior chamber cosmetic iris implants permanently alter the apparent iris color. Previous reports of these implants highlight adverse outcomes with severe ocular morbidity, including glaucoma, corneal endothelial decompensation, iris damage, and uveitis, which may result in vision loss.13 These reports concern the NewColorIris implant (Kahn Medical Devices). We report a case involving a new cosmetic iris implant, BrightOcular (Stellar Devices LLC), causing iris damage, uveitis, and corneal endothelial damage.

First Page Preview View Large
First page PDF preview
First page PDF preview
×